Welcome to LookChem.com Sign In|Join Free
  • or
6-methylergolin-8beta-amine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

51898-44-3

Post Buying Request

51898-44-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51898-44-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 51898-44-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,8,9 and 8 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 51898-44:
(7*5)+(6*1)+(5*8)+(4*9)+(3*8)+(2*4)+(1*4)=153
153 % 10 = 3
So 51898-44-3 is a valid CAS Registry Number.

51898-44-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-methyl-ergolin-8β-ylamine

1.2 Other means of identification

Product number -
Other names 8β-amino-6-methyl-ergoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51898-44-3 SDS

51898-44-3Downstream Products

51898-44-3Relevant academic research and scientific papers

Synthesis and antihypertensive activity of 2,4-dioxoimidazolidin-1-yl and perhydro-2,4-dioxopyrimidin-1-yl ergoline derivatives

Mantegani, Sergio,Brambilla, Enzo,Caccia, Carla,Chiodini, Laura,Ruggieri, Daniela,Lamberti, Ernesto,Di Salle, Enrico,Salvati, Patricia

, p. 293 - 304 (2007/10/03)

The synthesis and antihypertensive activity of a series of 2,4-dioxoimidazoldin-1-yl and perhydro-2,4-dioxopyrimidin-1-yl ergoline derivatives are reported. The oral antihypertensive activity was studied in spontaneously hypertensive rats (SHRs) by measuring systolic blood pressure by an indirect tail-cuff method at different times after treatment. The prolactin lowering activity (indirectly measured by the nidation test) in rats and the oral acute toxicity in mice were also studied. The results of this study revealed potent antihypertensive ergoline derivatives devoid of side-effects related to the dopaminergic stimulation and the importance of the Δ9,10 double bond for conferring high potency within these compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 51898-44-3